Literature DB >> 27790640

Risk Stratification in Arrhythmic Right Ventricular Cardiomyopathy Without Implantable Cardioverter-Defibrillators.

Francesca Brun1, Judith A Groeneweg2, Kathleen Gear3, Gianfranco Sinagra1, Jeroen van der Heijden4, Luisa Mestroni5, Richard N Hauer2, Mark Borgstrom6, Frank I Marcus3, Trina Hughes3.   

Abstract

OBJECTIVES: The primary objective of this study is risk stratification of patients with arrhythmic right ventricular cardiomyopathy (ARVC).
BACKGROUND: There is a need to identify those who need an automatic implantable defibrillator (ICD) to prevent sudden death.
METHODS: This is an analysis of 88 patients with ARVC from three centers who were not treated with an ICD.
RESULTS: Risk factors for subsequent arrhythmic deaths were pre-enrollment sustained or nonsustained ventricular tachycardia (VT) and decreased left ventricular function.
CONCLUSION: These factors serve as proposed guidelines for implantation of an ICD in patients with ARVC to prevent sudden death.

Entities:  

Keywords:  arrhythmogenesis; arrhythmogenic right ventricular cardiomyopathy; risk stratification in ARVC

Year:  2016        PMID: 27790640      PMCID: PMC5076865          DOI: 10.1016/j.jacep.2016.03.015

Source DB:  PubMed          Journal:  JACC Clin Electrophysiol        ISSN: 2405-500X


  31 in total

1.  Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention.

Authors:  Aditya Bhonsale; Cynthia A James; Crystal Tichnell; Brittney Murray; Dmitri Gagarin; Binu Philips; Darshan Dalal; Ryan Tedford; Stuart D Russell; Theodore Abraham; Harikrishna Tandri; Daniel P Judge; Hugh Calkins
Journal:  J Am Coll Cardiol       Date:  2011-09-27       Impact factor: 24.094

2.  Arrhythmogenic right ventricular cardiomyopathy/dysplasia clinical presentation and diagnostic evaluation: results from the North American Multidisciplinary Study.

Authors:  Frank I Marcus; Wojciech Zareba; Hugh Calkins; Jeffrey A Towbin; Cristina Basso; David A Bluemke; N A Mark Estes; Michael H Picard; Danita Sanborn; Gaetano Thiene; Thomas Wichter; David Cannom; David J Wilber; Melvin Scheinman; Henry Duff; James Daubert; Mario Talajic; Andrew Krahn; Michael Sweeney; Hasan Garan; Scott Sakaguchi; Bruce B Lerman; Charles Kerr; Jack Kron; Jonathan S Steinberg; Duane Sherrill; Kathleen Gear; Mary Brown; Patricia Severski; Slava Polonsky; Scott McNitt
Journal:  Heart Rhythm       Date:  2009-03-11       Impact factor: 6.343

3.  Prognostic predictors in arrhythmogenic right ventricular cardiomyopathy: results from a 10-year registry.

Authors:  Bruno Pinamonti; Andreea Mihaela Dragos; Stylianos A Pyxaras; Marco Merlo; Alberto Pivetta; Giulia Barbati; Andrea Di Lenarda; Tullio Morgera; Luisa Mestroni; Gianfranco Sinagra
Journal:  Eur Heart J       Date:  2011-02-28       Impact factor: 29.983

4.  The ICD for primary prevention in patients with inherited cardiac diseases: indications, use, and outcome: a comparison with secondary prevention.

Authors:  Louise R A Olde Nordkamp; Arthur A M Wilde; Jan G P Tijssen; Reinoud E Knops; Pascal F H M van Dessel; Joris R de Groot
Journal:  Circ Arrhythm Electrophysiol       Date:  2012-12-29

5.  Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia.

Authors:  Domenico Corrado; Hugh Calkins; Mark S Link; Loira Leoni; Stefano Favale; Michela Bevilacqua; Cristina Basso; Deirdre Ward; Giuseppe Boriani; Renato Ricci; Jonathan P Piccini; Darshan Dalal; Massimo Santini; Gianfranco Buja; Sabino Iliceto; N A Mark Estes; Thomas Wichter; William J McKenna; Gaetano Thiene; Frank I Marcus
Journal:  Circulation       Date:  2010-09-07       Impact factor: 29.690

Review 6.  Arrhythmogenic right ventricular cardiomyopathy. Antiarrhythmic drugs, catheter ablation, or ICD?

Authors:  Thomas Wichter; Thomas Matthias Paul; Lars Eckardt; Petra Gerdes; Paulus Kirchhof; Dirk Böcker; Günter Breithardt
Journal:  Herz       Date:  2005-03       Impact factor: 1.443

Review 7.  Natural history and risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy.

Authors:  Jean-Sébastien Hulot; Xavier Jouven; Jean-Philippe Empana; Robert Frank; Guy Fontaine
Journal:  Circulation       Date:  2004-09-27       Impact factor: 29.690

8.  Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers.

Authors:  Cynthia A James; Aditya Bhonsale; Crystal Tichnell; Brittney Murray; Stuart D Russell; Harikrishna Tandri; Ryan J Tedford; Daniel P Judge; Hugh Calkins
Journal:  J Am Coll Cardiol       Date:  2013-07-17       Impact factor: 24.094

9.  Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology.

Authors:  W J McKenna; G Thiene; A Nava; F Fontaliran; C Blomstrom-Lundqvist; G Fontaine; F Camerini
Journal:  Br Heart J       Date:  1994-03

10.  Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia.

Authors:  Domenico Corrado; Loira Leoni; Mark S Link; Paolo Della Bella; Fiorenzo Gaita; Antonio Curnis; Jorge Uriarte Salerno; Diran Igidbashian; Antonio Raviele; Marcello Disertori; Gabriele Zanotto; Roberto Verlato; Giuseppe Vergara; Pietro Delise; Pietro Turrini; Cristina Basso; Franco Naccarella; Francesco Maddalena; N A Mark Estes; Gianfranco Buja; Gaetano Thiene
Journal:  Circulation       Date:  2003-11-24       Impact factor: 29.690

View more
  5 in total

Review 1.  Sudden cardiac death in cardiomyopathies: acting upon "acceptable" risk in the personalized medicine era.

Authors:  Gherardo Finocchiaro; Emma F Magavern; Georgios Georgioupoulos; Niccolo' Maurizi; Gianfranco Sinagra; Gerald Carr-White; Antonis Pantazis; Iacopo Olivotto
Journal:  Heart Fail Rev       Date:  2022-01-27       Impact factor: 4.654

2.  Running the Risk: Exercise and Arrhythmogenic Cardiomyopathy.

Authors:  Lauren Eberly; Lohit Garg; Mahesh Vidula; Nosheen Reza; Sheela Krishnan
Journal:  Curr Treat Options Cardiovasc Med       Date:  2021-09-18

Review 3.  Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy.

Authors:  Hugh Calkins; Domenico Corrado; Frank Marcus
Journal:  Circulation       Date:  2017-11-21       Impact factor: 29.690

Review 4.  Cardiac magnetic resonance imaging: Which information is useful for the arrhythmologist?

Authors:  Elia De Maria; Annachiara Aldrovandi; Ambra Borghi; Letizia Modonesi; Stefano Cappelli
Journal:  World J Cardiol       Date:  2017-10-26

5.  Arrhythmogenic right ventricular cardiomyopathy.

Authors:  Yongkeun Cho
Journal:  J Arrhythm       Date:  2018-03-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.